How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,568 results for

Postpartum Office Visit

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

81. Barriers to Breastfeeding: Supporting Initiation and Continuation of Breastfeeding

diabetes mellitus, and cardiovascular disease among women Decreased rates of ovarian and breast cancer in women Improved return to prepregnancy weight Improved birth spacing Data from Lawrence RA, Lawrence RM. Breastfeeding: a guide for the medical profession. 7th ed. Maryland Heights, MO: Elsevier Mosby; 2011; Chua S, Arulkumaran S, Lim I, Selamat N, Ratnam SS. Influence of breastfeeding and nipple stimulation on postpartum uterine activity. Br J Obstet Gynaecol 1994;101:804–5; Rosenblatt KA, Thomas (...) Organization Code of Marketing of Breast Milk Substitutes, which, among other requirements, stipulates that “facilities of health care systems should not be used for the display of products within the scope of this Code, for placards or posters concerning such products, or for the distribution of material provided by a manufacturer or distributor” . Obstetrician–gynecologists and other health care professionals should be aware that the in-office or in-hospital advertising and distribution of gift packs

2021 American College of Obstetricians and Gynecologists

82. Breastfeeding Challenges

are essential to help obstetrician–gynecologists and other obstetric care professionals distinguish the specific cause of their patients’ pain and determine appropriate treatment. Studies have shown that pain with breastfeeding may be associated with postpartum depression; therefore, postpartum depression screening is an important part of the medical history when caring for these patients . Box 2. Example Case: Persistent Pain Example Case: A primipara woman presents to your office 1 week postpartum (...) and early-term infants can be found at Academy of Breastfeeding Medicine Clinical Protocol #10: Breastfeeding the Late Preterm (34–36 6/7 Weeks of Gestation) and Early Term Infants (37–38 6/7 Weeks of Gestation) . Box 6. Example Case: Breastfeeding Late-Preterm and Early-Term Infants Example case: A patient with a history of abdominal myomectomy presents to your office for a prenatal visit at 35 weeks of gestation. She has been counseled previously that she will need to have a scheduled primary cesarean

2021 American College of Obstetricians and Gynecologists

83. Treatments for Acute Pain: A Systematic Review

No. 240. (Prepared by the Pacific Northwest Evidence-based Practice Center under Contract No. 290- 2015-00009-I.) AHRQ Publication No. 20(21)-EHC006. Rockville, MD: Agency for Healthcare Research and Quality; December 2020. DOI: https://doi.org/10.23970/AHRQEPCCER240. Posted final reports are located on the Effective Health Care Program search page. iii Preface The Agency for Healthcare Research and Quality (AHRQ), through its Evidence-based Practice Centers (EPCs), sponsors the development (...) prior to their release as a final report. AHRQ expects that the EPC evidence reports and technology assessments, when appropriate, will inform individual health plans, providers, and purchasers as well as the healthcare system as a whole by providing important information to help improve healthcare quality. If you have comments on this systematic review, they may be sent by mail to the Task Order Officer named below at: Agency for Healthcare Research and Quality, 5600 Fishers Lane, Rockville, MD

2021 Effective Health Care Program (AHRQ)

84. Mega-map of systematic reviews and evidence and gap maps on the interventions to improve child well-being in low- and middle-income countries Full Text available with Trip Pro

term Search term EVIDENCE AND GAP MAP Open Access Mega‐map of systematic reviews and evidence and gap maps on the interventions to improve child well‐being in low‐ and middle‐income countries Corresponding Author Campbell South Asia, Vasant Kunj, Delhi, India Correspondence Ashrita Saran, Campbell South Asia, 2nd Floor, West Wing, ISID Complex, Vasant Kunj, Delhi, 110070, India. Email: Campbell Collaboration, Vasant Kunj, Delhi, India UNICEF Office of Research‐Innocenti, Florence, Italy Philippines (...) Institute of Development Studies, Manila, Philippines Corresponding Author Campbell South Asia, Vasant Kunj, Delhi, India Correspondence Ashrita Saran, Campbell South Asia, 2nd Floor, West Wing, ISID Complex, Vasant Kunj, Delhi, 110070, India. Email: Campbell Collaboration, Vasant Kunj, Delhi, India UNICEF Office of Research‐Innocenti, Florence, Italy Philippines Institute of Development Studies, Manila, Philippines First published: 28 October 2020 Linked Article: Give access Share full-text access

2020 Campbell Collaboration

85. Remote digital delivery of real-time psychotherapy compared with face-to-face therapy for depression or anxiety (including post-traumatic stress disorder)

incorporated patients meeting clinical criteria for a depressive disorder (78 studies) or patients who scored above a cut-off on a self-reported score (77 studies). Eleven studies were in women with post-natal depression. Studies selected for inclusion in the NMA either compared treatment modalities or compared a treatment modality with a control condition. The relevant comparisons for this assessment were telephone-based CBT compared with individual or group face-to-face CBT. Acceptability was defined (...) Remote digital delivery of real-time psychotherapy compared with face-to-face therapy for depression or anxiety (including post-traumatic stress disorder) SHTG Assessment | 1 SHTG Assessment 01-21 January 2021 Remote digital delivery of real-time psychotherapy compared with face-to-face therapy for depression or anxiety (including post-traumatic stress disorder) What were we asked to look at? NHS Education for Scotland (NES) asked us to review the published evidence on the effectiveness

2021 SHTG Advice Statements

86. Consumer Testing for Disease Risk

and pharmacogenetics recently have been marketed directly to consumers, and whereas some results may be reliable and accurate, the validity of others is less certain. Vignette #1 A 30-year-old patient, gravida 1, presents for a routine prenatal visit. She reports that she recently received results from a direct-to-consumer genetic testing laboratory and the results indicated that she was at increased risk for bleeding due to Factor XI deficiency. She is concerned about bleeding during her upcoming labor (...) and delivery. She has no history of heavy menstrual bleeding or excessive bleeding during a prior childhood surgery. She relates that her sister had a postpartum hemorrhage requiring a transfusion after delivery of twins. As a result of the direct-to-consumer genetic testing result, you order a plasma Factor XI activity to assess her bleeding risk, and her Factor XI activity is within the normal range, indicating that she is not at increased risk for bleeding due to a Factor XI deficiency. You explain

2021 American College of Obstetricians and Gynecologists

87. Coronavirus (COVID-19) infection and pregnancy

postnatal), and one woman died during the extended postpartum period (up to 1 year). 16 Of these ten women, seven died of COVID-19, in one the cause of death was undetermined but was considered to be probably related to COVID-19, and two died of unrelated causes. It is, at this time, unclear whether the pandemic will result in a statistically significant impact on the overall rate of maternal death in the UK. Key lessons from the report of these deaths have been incorporated into this guidance. 1.4.3 (...) Coronavirus (COVID-19) infection and pregnancy 1 Information for healthcare professionals Version 12: Published Wednesday 14 October 2020 Coronavirus (COVID-19) Infection in Pregnancy2 Contents Summary of updates 3–5 1 Purpose and scope 6–12 2 Antenatal care during the COVID-19 pandemic 13–22 3 Venous thromboembolism prevention 23–25 4 Labour and birth during the COVID-19 pandemic 26–35 5 Managing clinical deterioration during the COVID-19 pandemic 36–42 6 Postnatal care 43–47 7 Acknowledgments

2020 Royal College of Obstetricians and Gynaecologists

88. Acute pain management: scientific evidence (5th Edition)

to members: American?Academy?of?Pain?Medicine? ? ? ? Approved by the NHMRC on 4 February 2010 © Australian and New Zealand College of Anaesthetists 2010 ISBN Print: 978-0-977517-4-4-2 Online: 978-0-9775174-5-9 This work is copyright. Apart from any use as permitted under the Copyright Act 1968, no part may be reproduced by any process without prior written permission from ANZCA. Requests and enquiries concerning reproduction and rights should be addressed to the Chief Executive Officer, Australian (...) obtained from case series, either post-test or pre-test and post-test Clinical practice points ? Recommended best practice based on clinical experience and expert opinion Key messages Key messages for each topic are given with the highest level of evidence available to support them, or with a symbol indicating that they are based on clinical experience or expert opinion. In the key messages, Level I evidence from the Cochrane Database is identified. Levels of evidence were documented according

2020 National Health and Medical Research Council

89. Antibody Response Following SARS-CoV-2 Infection and Implications for Immunity: A Living Rapid Review

the relationship between the development of antibodies after RT-PCR-diagnosed SARS-CoV-2 infection and the risk of reinfection. Studies based on index serologic testing suggest that the presence of antibodies is associated with a lower risk of a subsequent positive SARS-CoV-2 RT-PCR test. 5 Methods This review followed standard methods and guidelines for conducting and reporting of systematic reviews. 6,7 The review protocol was developed with input from ACP and AHRQ staff and was publicly posted on the AHRQ (...) evidence that would change the nature or strength of our conclusions, or every 4 months (whichever is sooner). Surveillance reports and review updates will be publicly posted on the AHRQ EHC Program website. 7 Evidence Base The literature flow diagram (Figure 1) summarizes the results of the search and study selection process. 15 After screening 3,937 citations identified through database searching and 87 additional citations found through hand-searching, we included 66 observational studies. 15-80

2021 Effective Health Care Program (AHRQ)

90. The 2020 Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease

257 Mechanical valve thrombosis 257 Cardiac surgery during pregnancy 258 Other drugs in pregnancy and lactation 258 Labour, birth and the post-partum period 259 Method of birth 259 Infective endocarditis prophylaxis 259 Medications to treat post-partum haemorrhage 259CONTENTS ix 13 14 12 Pre-discharge 260 Discharge plan 260 Conception planning 260 RHD register and secondary prophylaxis 260 Post-discharge 260 Australian classification for medicines in pregnancy 264 Case studies 265 References 269 (...) Evidence of streptococcal A infection 90 Streptococcus A rapid diagnostics 90 Streptococcal serology in high-incidence populations 91 Differential diagnosis 91 Syndromes that may be confused with ARF 92 Post-streptococcal reactive arthritis 92 Paediatric autoimmune neuropsychiatric disorders associated with strep A infections 92 Echocardiography and ARF 93 Valvulitis: minimal echocardiographic criteria for pathological regurgitation 95 Morphological changes associated with rheumatic carditis 96

2021 Cardiac Society of Australia and New Zealand

91. Automated-Entry Patient-Generated Health Data for Chronic Conditions: The Evidence on Health Outcomes

Research and Quality (AHRQ). Suggested citation: Treadwell JR, Reston JT, Rouse B, Fontanarosa J, Patel N, Mull NK. Automated-Entry Patient-Generated Health Data for Chronic Conditions: The Evidence on Health Outcomes. Technical Brief No. 38 (Prepared by the ECRI-Penn Evidence-based Practice Center under Contract No. 290-2015-00005-I.) AHRQ Publication No. 21-EHC012. Rockville, MD: Agency for Healthcare Research and Quality. March 2021. Posted final reports are located on the Effective Health Care (...) as the health care system as a whole by providing important information to help improve health care quality. If you have comments on this Technical Brief, they may be sent by mail to the Task Order Officer named below at: Agency for Healthcare Research and Quality, 5600 Fishers Lane, Rockville, MD 20857, or by email to epc@ahrq.hhs.gov. David Meyers, M.D. Acting Director Agency for Healthcare Research and Quality Christine Chang M.D., M.P.H. Acting Director Evidence-based Practice Center Program Center

2021 Effective Health Care Program (AHRQ)

92. AAES Guidelines for the Definitive Surgical Management of Thyroid Disease in Adults

”) is due to excess secretion of thyroid hormone from the thyroid gland. Approximately 1.2% of the US population has hyperthyroidism, which can be characterized as nodular (Plummer disease) or diffuse. The most common etiology is Graves disease (GD), followed by toxic multinodular goiter (TMNG) and toxic adenoma (TA). Thyrotoxicosis can be autoimmune (GD, Hashimoto's thyroiditis), drug-induced (amiodarone, lithium, cytokine, tyrosine-kinase inhibitors, immunotherapy), or postpartum. GD is the most (...) invasion of the capsule or microvasculature and does not have nuclear features of PTC. FA are typically solitary and may contain papillary hyperplasia (papillary cytoarchitecture without nuclear features of PTC). Post-FNAB pseudo-invasion can be distinguished from true capsular invasion by identifying evidence of inflammatory/fibrotic reaction along the needle track. Some FA have pleomorphism, mitoses, and necrosis but not invasion and are considered precursor lesions to poorly differentiated

2021 American Association of Endocrine Surgeons

93. Hypertension and pregnancy

are free to copy and communicate the work in its current form for non-commercial purposes, as long as you attribute Queensland Clinical Guidelines, Queensland Health and abide by the licence terms. You may not alter or adapt the work in any way. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc- nd/3.0/au/deed.en For further information contact Queensland Clinical Guidelines, RBWH Post Office, Herston Qld 4029, email Guidelines@health.qld.gov.au, phone (07) 3131 6777 (...) BP measurement • Correct measurement techniques are critical to the correct diagnosis of HDP 18 • Confirm non-severe hypertension by measuring BP over several hours o Up to 70% of women with an office BP of 140/90 mmHg have normal BP on subsequent measurements on the same visit 17 • Refer to Appendix A: Measurement of blood pressure Proteinuria • Screen women for proteinuria with urinary dipstick at each visit 17 1 • Quantify by laboratory methods if: o Greater than or equal to 2+ proteinuria

2021 Queensland Health

94. Gestational diabetes mellitus

licence. In essence, you are free to copy and communicate the work in its current form for non-commercial purposes, as long as you attribute Queensland Clinical Guidelines, Queensland Health and abide by the licence terms. You may not alter or adapt the work in any way. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc- nd/3.0/au/deed.en For further information contact Queensland Clinical Guidelines, RBWH Post Office, Herston Qld 4029, email Guidelines@health.qld.gov.au (...) system for women and their GP about the importance of post natal OGTT Queensland Clinical Guideline: Gestational diabetes mellitus Refer to online version, destroy printed copies after use Page 12 of 38 2 Risk assessment Abnormalities of glucose tolerance have immediate, short-term, and long-term implications for the health of the woman and her baby 6 which may be prevented by adequate treatment. 12-14 Discuss with all women the benefits of achieving or maintaining a healthy lifestyle (e.g. nutrition

2021 Queensland Health

95. Maternity care for mothers and babies during the COVID-19 pandemic

current form for non-commercial purposes, as long as you attribute Queensland Clinical Guidelines, Queensland Health and abide by the licence terms. You may not alter or adapt the work in any way. To view a copy of this licence, visit https://creativecommons.org/licenses/by-nc-nd/4.0/deed.en For further information, contact Queensland Clinical Guidelines, RBWH Post Office, Herston Qld 4029, email Guidelines@health.qld.gov.au, For permissions beyond the scope of this licence, contact: Intellectual (...) period 2.2 Visiting in-patient mothers and babies Table 4. Hospital visiting Aspect Consideration Visitor restrictions • Limit number of visitors 21,22 to minimise potential for virus spread • Hospital visits have been restricted by the Chief Health Officer (in accordance with emergency powers arising from a declared public health emergency) 21 • No hospital visiting by a person: o Confirmed as COVID-19 positive o Under 16 years of age o Who has been asked to self-quarantine o Is unwell, particularly

2021 Queensland Health

96. Neonatal medicines

and communicate the work in its current form for non-commercial purposes, as long as you attribute Queensland Clinical Guidelines, Queensland Health and abide by the licence terms. You may not alter or adapt the work in any way. To view a copy of this licence, visit https://creativecommons.org/licenses/by-nc-nd/4.0/deed.en For further information, contact Queensland Clinical Guidelines, RBWH Post Office, Herston Qld 4029, email Guidelines@health.qld.gov.au, phone (07) 3131 6777. For permissions beyond (...) the scope of this licence, contact: Intellectual Property Officer, Queensland Health, GPO Box 48, Brisbane Qld 4001, email ip_officer@health.qld.gov.au, phone (07) 3234 1479. Cultural acknowledgement We acknowledge the Traditional Custodians of the land on which we work and pay our respect to the Aboriginal and Torres Strait Islander elders past, present and emerging. Queensland Clinical Guideline: Neonatal medicines Refer to online version, destroy printed copies after use Page 3 of 20 Abbreviations IM

2021 Queensland Health

97. 2021 ACC/AHA Key Data Elements and Definitions for Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Heart Failure) Full Text available with Trip Pro

reprints, call 215-356-2721 or email . The expert peer review of AHA-commissioned documents (eg, scientific statements, clinical practice guidelines, systematic reviews) is conducted by the AHA Office of Science Operations. For more on AHA statements and guidelines development, visit . Select the “Guidelines & Statements” drop-down menu near the top of the webpage, then click “Publication Development.” Permissions: Multiple copies, modification, alteration, enhancement, and/or distribution (...) , and EHR communities. 2.7. Peer Review, Public Review, and Board Approval This document was reviewed by official reviewers nominated by ACC and AHA. To increase its applicability further, the document was posted on the ACC and AHA websites for a 30-day public comment period. This document was approved for publication by the ACC Clinical Policy Approval Committee in October 2020, by the AHA Science Advisory and Coordinating Committee in September 2020, and by the AHA Executive Committee in December 2020

2021 American Heart Association

98. Cervical Ripening in the Outpatient Setting

. Comparative Effectiveness Review No. 238. (Prepared by the Pacific Northwest Evidence-based Practice Center under Contract No. 290-2015-00009-I for the Agency for Healthcare Research and Quality and the Patient-Centered Outcomes Research Institute.) AHRQ Publication No. 21- EHC011. PCORI Publication No. 2020-SR-03. Rockville, MD: Agency for Healthcare Research and Quality; March 2021. DOI: https://doi.org/10.23970/AHRQEPCCER238. Posted final reports are located on the Effective Health Care Program search (...) in the selected scientific area, identify methodological and scientific weaknesses, suggest research needs, and move the field forward through an unbiased, evidence-based assessment of the available literature. Thus, EPC evidence reports may inform individual health plans, providers, and purchasers as well as the healthcare system as a whole by providing important information to help improve healthcare quality. If you have comments on this evidence report, they may be sent by mail to the Task Order Officer

2021 Effective Health Care Program (AHRQ)

99. Adverse Pregnancy Outcomes and Cardiovascular Disease Risk: Unique Opportunities for Cardiovascular Disease Prevention in Women Full Text available with Trip Pro

practice guidelines, systematic reviews) is conducted by the AHA Office of Science Operations. For more on AHA statements and guidelines development, visit . Select the “Guidelines & Statements” drop-down menu, then click “Publication Development.” Permissions: Multiple copies, modification, alteration, enhancement, and/or distribution of this document are not permitted without the express permission of the American Heart Association. Instructions for obtaining permission are located at . A link (...) disease, stroke, peripheral vascular disease, and heart failure). This statement highlights the importance of recognizing APOs when CVD risk is evaluated in women, although their value in reclassifying risk may not be established. A history of APOs is a prompt for more vigorous primordial prevention of CVD risk factors and primary prevention of CVD. Adopting a heart-healthy diet and increasing physical activity among women with APOs, starting in the postpartum setting and continuing across the life

2021 American Heart Association

100. Maternal, Fetal, and Child Outcomes of Mental Health Treatments in Women: A Systematic Review of Perinatal Pharmacologic Interventions

to the Effective Health Care Program. Please visit the website (www.effectivehealthcare.ahrq.gov) to see draft research questions and reports or to join an email list to learn about new program products and opportunities for input. If you have comments on this systematic review, they may be sent by mail to the Task Order Officer named below at: Agency for Healthcare Research and Quality, 5600 Fishers Lane, Rockville, MD 20857, or by email to epc@ahrq.hhs.gov. David Meyers, M.D. Arlene S. Bierman, M.D., M.S (...) expertise throughout the development of the review. The final protocol is posted on the EHC website at https://effectivehealthcare.ahrq.gov/products/mental-health-pregnancy/protocol. The PROSPERO registration is CRD42019124057. Key Questions The following KQs and Contextual Question (CQ) guided our systematic review. KQ 1. Among pregnant and postpartum women, what is the effectiveness of pharmacologic interventions on maternal outcomes a. Among those with a new or preexisting anxiety disorder? b. Among

2021 Effective Health Care Program (AHRQ)

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>